Request Demo
Last update 27 Feb 2026
RO-7565020
Last update 27 Feb 2026
Overview
Basic Info
Drug Type Biological products |
Synonyms RO 7565020, RO7565020 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with RO-7565020CTIS2022-502579-46-00
- BP44118
NCT05763576
A Phase I Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7565020 in Healthy Participants and in Participants With Chronic Hepatitis B Virus Infection
100 Clinical Results associated with RO-7565020
Login to view more data
100 Translational Medicine associated with RO-7565020
Login to view more data
100 Patents (Medical) associated with RO-7565020
Login to view more data
100 Deals associated with RO-7565020
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatitis B, Chronic | Phase 1 | United States | 17 Apr 2023 | |
| Hepatitis B, Chronic | Phase 1 | United States | 17 Apr 2023 | |
| Hepatitis B, Chronic | Phase 1 | Bulgaria | 17 Apr 2023 | |
| Hepatitis B, Chronic | Phase 1 | Bulgaria | 17 Apr 2023 | |
| Hepatitis B, Chronic | Phase 1 | France | 17 Apr 2023 | |
| Hepatitis B, Chronic | Phase 1 | France | 17 Apr 2023 | |
| Hepatitis B, Chronic | Phase 1 | New Zealand | 17 Apr 2023 | |
| Hepatitis B, Chronic | Phase 1 | New Zealand | 17 Apr 2023 | |
| Hepatitis B, Chronic | Phase 1 | South Korea | 17 Apr 2023 | |
| Hepatitis B, Chronic | Phase 1 | South Korea | 17 Apr 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1 | 60 | placebo+RO7565020 (Part 1a Placebo) | wxxvwukzpd = whsdxmazzr gvitukfelg (kiugywumsy, gahqyqvwqg - ipotdcarkh) View more | - | 22 Jan 2026 | ||
(Part 1a Cohort 1) | wxxvwukzpd = uoutrbdzeb gvitukfelg (kiugywumsy, jmvusevnor - geeiywkrxs) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free